MiNK Therapeutics, Inc.INKTNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
40.01%
↑ 101% vs avg
Percentile
P86
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-3370.88%
Historical baseline
PeriodValue
Q3 202540.01%
Q2 202599.88%
Q1 2025-77511.95%
Q4 202442.31%
Q3 2024-30.74%
Q2 20249.89%
Q1 202416.26%
Q4 202327.87%
Q3 2023-1.40%
Q2 20234.93%
Q1 20231.45%
Q4 202221.09%
Q3 2022-21.40%
Q2 2022-10.21%
Q1 2022-146.52%
Q4 202151.31%
Q3 2021-2.21%
Q2 202118.73%
Q1 2021-145.02%
Q4 202033.48%
Q3 2020-27.92%
Q2 20200.00%
Q1 20200.00%